REGENERON PHARMACEUTICALS, INC. (REGN) /
The debt of REGENERON PHARMACEUTICALS, INC. over the past 10 years
Chart REGENERON PHARMACEUTICALS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, REGENERON PHARMACEUTICALS, INC. had liquid cash of $8.61B and total debt of $1.99B: net cash of $6.62B. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2025 ($1.99B) and lowest at the end of fiscal 2016 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $8.61B* | $1.99B | $6.62B |
| 2024ended Dec 31, 2024 | $9.01B* | $1.98B | $7.03B |
| 2023ended Dec 31, 2023 | $10.84B* | $1.98B | $8.86B |
| 2022ended Dec 31, 2022 | $7.74B* | $1.98B | $5.76B |
| 2021ended Dec 31, 2021 | $5.69B* | $1.98B | $3.71B |
| 2020ended Dec 31, 2020 | $3.59B* | $1.98B | $1.61B |
| 2019ended Dec 31, 2019 | $3.21B* | $0 | $3.21B |
| 2018ended Dec 31, 2018 | $2.81B* | $0 | $2.81B |
| 2017ended Dec 31, 2017 | $1.41B* | $0 | $1.41B |
| 2016ended Dec 31, 2016 | $1.04B* | $0 | $1.04B |
Fiscal years as REGENERON PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on REGENERON PHARMACEUTICALS, INC.
- The revenue of REGENERON PHARMACEUTICALS, INC.
- The profitability of REGENERON PHARMACEUTICALS, INC.
- The cash flow of REGENERON PHARMACEUTICALS, INC.
- The dividends of REGENERON PHARMACEUTICALS, INC.
- All of REGENERON PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- UPSUNITED PARCEL SERVICE INC
- TRVTravelers Companies, Inc.
- EOGEOG RESOURCES, INC.
- MCOMoody’s Corporation
- CDNSCADENCE DESIGN SYSTEMS, INC.
Not investment advice. This page shows what REGENERON PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.